Paul Arnold

2 weeks ago | today.westlaw.com | Friederike Heine |Paul Arnold |Matthias Williams

ZURICH (Reuters) -Hurricanes, storms, floods and other natural disasters may cause $145 billion in insured losses in 2025, nearly 6% up from 2024 and one of the costliest years on record, reinsurance company Swiss Re said in a report on Tuesday.

1 month ago | bilyonaryo.com | Paul Arnold |Maggie Fick

SOURCE: ReutersBy Paul Arnold, Maggie FickZURICH, March 19 (Reuters) – Swiss drugmaker Roche has abandoned global diverse workforce targets and compatriot Novartis is ending its use of diverse panels for U.S. hiring, the latest companies acting to avoid penalties from recent U.S. executive orders. Among its measures, Roche ROG.S said its Chief Diversity Offices in the U.S. and at its Basel headquarters “will focus on inclusion and belonging, and responsibilities will be re-scoped accordingly”.

1 month ago | kfgo.com | Paul Arnold |Maggie Fick

By Paul Arnold and Maggie Fick ZURICH (Reuters) -Swiss drugmaker Novartis is ending its use of diverse panels for all of its hiring in the United States, the company told Reuters on Wednesday, citing the changing legal and policy landscape surrounding diversity in the U.S. A number of U.S. and European companies have ditched or scaled back their diversity, equity and inclusion programmes since U.S. President Donald Trump declared some elements of DEI illegal and threatened to investigate...

1 month ago | marketscreener.com | Paul Arnold |Maggie Fick

ZURICH (Reuters) -Swiss drugmaker Novartis is ending its use of diverse panels for all of its hiring in the United States, the company told Reuters on Wednesday, citing the changing legal and policy landscape surrounding diversity in the U.S.A number of U.S. and European companies have ditched or scaled back their diversity, equity and inclusion programmes since U.S. President Donald Trump declared some elements of DEI illegal and threatened to investigate companies over them.

1 month ago | gazette.com | Paul Arnold |Maggie Fick

By Paul Arnold, Maggie FickZURICH (Reuters) -Swiss drugmaker Roche has abandoned global diverse workforce targets and compatriot Novartis is ending its use of diverse panels for U.S. hiring, the latest companies acting to avoid penalties from recent U.S. executive ordersAmong its measures, Roche said its Chief Diversity Offices in the U.S. and at its Basel headquarters "will focus on inclusion and belonging, and responsibilities will be re-scoped accordingly".